Highest Score

Ranked by analysis score
Ranks this page's recent reports by score.
AAON, Inc.
AAON·Industrials
B ★★★Hold
Current$89.24
Target$104.00
Return+16.5%
Aug 13, 2026

AAON is rapidly capturing the multi-billion dollar AI data center liquid cooling market with its visionary BASX division, but temporary gross margin compression from aggressive facility expansions and stretched absolute valuations warrant a cautious accumulation strategy.

Score
75
Hims & Hers Health, Inc.
HIMS·Healthcare
B ★★★Hold
Current$31.59
Target$40.00
Return+26.6%
Aug 13, 2026

Hims & Hers is a hyper-growth telehealth disruptor riding the GLP-1 wave, but faces intense margin pressure and existential regulatory threats over drug compounding.

Score
75
Celsius Holdings, Inc.
CELH·Consumer Staples
B ★★★Hold
Current$27.81
Target$44.80
Return+61.1%
Aug 12, 2026

Celsius has successfully cemented a dominant 20% domestic market share and trades at a historically cheap forward valuation, though investors must endure painful near-term volatility as management navigates aggressive SKU rationalization and emerging regulatory scrutiny.

Score
75
Applied Digital Corporation
APLD·Technology
B ★★★Hold
Current$29.69
Target$70.40
Return+137.1%
Aug 12, 2026

Applied Digital is a hyper-growth infrastructure powerhouse possessing a staggering $36 billion take-or-pay AI lease backlog, though investors must tolerate extreme debt-fueled cash burn and persistent execution risks regarding power grid energization.

Score
75
Mobileye Global Inc.
MBLY·Consumer Discretionary
B ★★★Hold
Current$8.73
Target$12.10
Return+38.6%
Aug 12, 2026

Mobileye possesses an unparalleled, highly profitable global ADAS monopoly generating immense free cash flow, but investors must remain sidelined until the company proves it can overcome devastating Chinese tariff headwinds, thwart Qualcomm's unified-compute threat, and execute a seamless post-founder leadership transition.

Score
75
UGI Corporation
UGI·Utilities
B ★★★Hold
Current$33.99
Target$41.30
Return+21.5%
Aug 12, 2026

While UGI offers a massive, highly discounted safety margin underpinned by a robustly growing, cash-generating regulated utility network, investors must remain sidelined until management permanently arrests the structural customer attrition devouring its AmeriGas propane division.

Score
75
Builders FirstSource, Inc.
BLDR·Industrials
B ★★★Hold
Current$71.98
Target$80.00
Return+11.1%
Aug 12, 2026

Builders FirstSource possesses a dominant market position and excellent capital allocation track record, but severe near-term housing headwinds, margin compression, and elevated leverage mandate a neutral stance until cycle visibility improves.

Score
75
MP Materials Corp.
MP·Materials
B ★★★Hold
Current$54.19
Target$67.44
Return+24.4%
Aug 12, 2026

MP Materials is a geopolitically indispensable, sovereign-backed monopoly executing a high-risk transition into domestic magnet manufacturing, insulated from commodity crashes by defense subsidies but heavily burdened by extreme valuation premiums and aggressive insider selling.

Score
75
StoneX Group Inc.
SNEX·Financials
B ★★★Hold
Current$65.84
Target$78.30
Return+18.9%
Aug 12, 2026

StoneX operates a globally dominant, highly resilient physical commodities and clearing tollbooth poised for structural growth, though near-term momentum is severely capped by heavy insider selling, a recent earnings miss, and mathematically acute vulnerability to falling interest rates.

Score
75
AECOM
ACM·Industrials
B ★★★Hold
Current$73.30
Target$108.00
Return+47.3%
Aug 12, 2026

AECOM is an unrivaled, deeply undervalued infrastructure consulting giant riding massive secular tailwinds in AI data centers and environmental remediation, but investors must endure a prolonged period of cash flow compression caused by severe execution failures on toxic legacy construction contracts.

Score
75
Bruker Corporation
BRKR·Healthcare
B ★★★Hold
Current$56.32
Target$63.00
Return+11.9%
Aug 11, 2026

Bruker is an undisputed scientific instruments monopolist currently suffering from self-inflicted debt and integration indigestion, offering patient investors a deeply discounted entry point into the explosive spatial biology supercycle once operational margins mathematically recover.

Score
75
Voya Financial, Inc.
VOYA·Financials
B ★★★Hold
Current$101.40
Target$106.93
Return+5.5%
Aug 12, 2026

Voya Financial is a cash-rich, capital-light retirement juggernaut fortified by an aggressive share repurchase mandate, currently locked in a tense standoff with activists that provides a massive M&A safety net beneath its temporary operational stumbles.

Score
75
FirstCash Holdings, Inc.
FCFS·Financials
B ★★★Hold
Current$209.01
Target$254.75
Return+21.9%
Aug 12, 2026

FirstCash is an elite, counter-cyclical compounder dominating the international pawn space with massive M&A tailwinds, but its steep premium valuation demands flawless execution and leaves it vulnerable to non-prime credit shocks.

Score
75
Life Time Group Holdings, Inc.
LTH·Consumer Discretionary
B ★★★Hold
Current$42.46
Target$49.00
Return+15.4%
Aug 12, 2026

Life Time operates an unparalleled, high-margin luxury athletic ecosystem with massive pricing power and phenomenal cash generation, but an unforgiving valuation premium and structural reliance on a fragile commercial real estate market dictate a cautious holding pattern.

Score
75
Viavi Solutions Inc.
VIAV·Technology
B ★★★Hold
Current$38.92
Target$60.00
Return+54.2%
Aug 12, 2026

Viavi is a highly profitable, indispensable technological tollbooth for the global AI data center networking buildout, boasting an explosive earnings trajectory that is unfortunately tempered by demanding valuation multiples and structurally aggressive equity dilution policies.

Score
75
Hut 8 Corp.
HUT·Financials
B ★★★Hold
Current$85.66
Target$115.83
Return+35.2%
Aug 11, 2026

Hut 8 is executing a massive pivot from Bitcoin mining to AI infrastructure, leveraging an 8.3 GW power moat to secure $26.6 billion in hyperscaler leases despite extreme transitionary multiples.

Score
75
Lineage, Inc.
LINE·Real Estate
B ★★★Hold
Current$41.35
Target$48.80
Return+18.0%
Aug 12, 2026

Lineage offers a compelling mid-single-digit dividend yield and stabilizing physical occupancy rates, but investors must remain highly vigilant regarding its elevated debt load and the ongoing margin pressure from high power and labor costs across its warehouse network.

Score
75
Pearson plc
PSO·Communication Services
B ★★★Hold
Current$15.89
Target$17.48
Return+10.0%
Aug 12, 2026

Pearson operates a formidable, cash-rich assessment and certification monopoly capable of funding massive shareholder returns, though its valuation premium and ongoing vulnerability to AI-driven disruption in legacy higher education mandate a cautious stance.

Score
75
Korea Electric Power Corporation
KEP·Utilities
B ★★★Hold
Current$12.49
Target$15.48
Return+23.9%
Aug 10, 2026

Korea Electric Power is an unassailable, deeply undervalued state monopoly sitting at the heart of South Korea's AI and electrification supercycle, yet its equity upside remains structurally throttled by extreme debt levels and government-mandated tariff suppression that prioritizes national inflation control over shareholder returns.

Score
75
Rocket Companies, Inc.
RKT·Financials
B ★★★Hold
Current$13.72
Target$17.35
Return+26.5%
Aug 10, 2026

Rocket Companies has forged an unparalleled, AI-driven homeownership monopoly following the Redfin and Mr. Cooper acquisitions, but investors must maintain a neutral stance as the company navigates severe equity dilution, complex M&A integration friction, and a perilous FTC antitrust trial.

Score
75
Solaris Energy Infrastructure, Inc.
SEI·Energy
B ★★★Hold
Current$57.96
Target$94.13
Return+62.4%
Aug 11, 2026

Solaris Energy has brilliantly cornered the critical bottleneck of the AI revolution by securing gigawatts of mobile power for hyperscalers, yet investors must carefully balance this unparalleled structural growth against the immense debt leverage required to fund it and the looming threat of environmental regulation.

Score
75
CG Oncology, Inc.
CGON·Healthcare
B ★★★Hold
Current$75.10
Target$91.00
Return+21.2%
Aug 10, 2026

CG Oncology possesses a highly effective, deeply derisked, and fully funded bladder-sparing viral immunotherapy, but investors must cautiously weigh its premium multi-billion-dollar valuation against the impending commercial onslaught from Johnson & Johnson's competing TAR-200 device.

Score
75
Casella Waste Systems, Inc.
CWST·Industrials
B ★★★Hold
Current$89.41
Target$110.00
Return+23.0%
Aug 10, 2026

Casella is a highly resilient, cash-generating regional waste monopoly thriving on aggressive roll-up acquisitions and impenetrable landfill permitting moats, though new investors must navigate a precarious, perfection-priced valuation multiple.

Score
75
Chunghwa Telecom Co., Ltd.
CHT·Communication Services
B ★★★Hold
Current$42.52
Target$41.82
Return-1.6%
Aug 10, 2026

Chunghwa Telecom is an impregnable, high-yielding digital monopoly successfully transforming into an Asia-Pacific AI infrastructure hub, but its extreme premium valuation leaves virtually no room for capital appreciation, cementing its role strictly as a defensive bond proxy.

Score
75